Search Results - "IMATAKI, O"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Micafungin Does Not Influence the Concentration of Tacrolimus in Patients After Allogeneic Hematopoietic Stem Cell Transplantation by Fukuoka, N, Imataki, O, Ohnishi, H, Kitanaka, A, Kubota, Y, Ishida, T, Tanaka, T

    Published in Transplantation proceedings (01-09-2010)
    “…Abstract Background Tacrolimus is commonly used in stem cell transplant recipients for prophylaxis of graft-vs-host disease. Micafungin is widely used as a…”
    Get full text
    Journal Article
  5. 5

    Insufficient ex vivo expansion of Vα24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells by Imataki, O, Heike, Y., MD, PhD, Makiyama, H, Iizuka, A, Ikarashi, Y, Ishida, T, Wakasugi, H, Takaue, Y

    Published in Cytotherapy (Oxford, England) (2008)
    “…Background Vα24+ natural killer T (NKT) cell is a human counterpart of mice Vα14+ NKT cell that has a regulatory role for innate and acquired potential…”
    Get full text
    Journal Article
  6. 6

    Insufficient ex vivo expansion of V alpha 24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells by Imataki, O, Heike, Y, Makiyama, H, Iizuka, A, Ikarashi, Y, Ishida, T, Wakasugi, H, Takaue, Y

    Published in Cytotherapy (Oxford, England) (01-01-2008)
    “…Background V alpha 24+ natural killer T (NKT) cell is a human counterpart of mice V alpha 14+ NKT cell that has a regulatory role for innate and acquired…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies by HAMAKI, T, KAMI, M, HEIKE, Y, TANOSAKI, R, MASUO, S, MIYAKOSHI, S, TANIGUCHI, S, TOBINAI, K, TAKAUE, Y, KIM, S-W, ONISHI, Y, KISHI, Y, MURASHIGE, N, HORI, A, KOJIMA, R, SAKIYAMA, M, IMATAKI, O

    Published in Bone marrow transplantation (Basingstoke) (01-05-2004)
    “…The purpose of this study was to evaluate the feasibility and efficacy of allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Insufficient ex vivo expansion of V 24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells by Imataki, O, Heike, Y, Makiyama, H, Iizuka, A, Ikarashi, Y, Ishida, T, Wakasugi, H, Takaue, Y

    Published in Cytotherapy (Oxford, England) (2008)
    “…Background V 24+ natural killer T (NKT) cell is a human counterpart of mice V 14+ NKT cell that has a regulatory role for innate and acquired potential…”
    Get full text
    Journal Article
  12. 12
  13. 13

    TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia by Urahama, Norinaga, Tanosaki, Ryuji, Masahiro, Kami, Iijima, Kimiko, Chizuka, Aki, Kim, Sung-Won, Hori, Akiko, Kojima, Rie, Imataki, Osamu, Makimito, Atsushi, Mineishi, Shin, Takaue, Yoichi

    Published in Transfusion (Philadelphia, Pa.) (01-11-2003)
    “…BACKGROUND:  TRALI is one of the most serious, life‐threatening complications after blood transfusion. Antibodies against neutrophils or HLA molecules from the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells by Imataki, O, Heike, Y, Makiyama, H, Iizuka, A, Ikarashi, Y, Ishida, T, Wakasugi, H, Takaue, Y

    Published in Cytotherapy (Oxford, England) (2008)
    “…Valpha24(+) natural killer T (NKT) cell is a human counterpart of mice Valpha14(+) NKT cell that has a regulatory role for innate and acquired potential…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20